ACORDA THERAP.NEW DL-001 – Underwriting Agreements – BamSEC

You must log in to view this page.

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Underwriting Agreements Filter

from 8-K 41 pages At the Market Offering Agreement January 13, 2021

from 8-K 39 pages Acorda Therapeutics, Inc. 1.75% Convertible Notes Due June 15, 2021 Underwriting Agreement June 17, 2014

from 8-K 36 pages Acorda Therapeutics, Inc. 4,000,000 Shares Common Stock Underwriting Agreement Dated August 6, 2008 Deutsche Bank Securities Inc. Underwriting Agreement

from 8-K 46 pages Acorda Therapeutics, Inc. 3,300,000 Shares Common Stock Underwriting Agreement Dated February 12, 2008 J.P. Morgan Securities Inc. Deutsche Bank Securities Inc. Underwriting Agreement

from 8-K 47 pages Acorda Therapeutics, Inc. 3,750,000 Shares Common Stock Underwriting Agreement Dated June 7, 2007 Banc of America Securities LLC Deutsche Bank Securities Inc. Underwriting Agreement

from S-1/A 41 pages Acorda Therapeutics, Inc. [•] Shares Common Stock Underwriting Agreement Dated [•], 2006 Banc of America Securities LLC Lazard Capital Markets LLC Piper Jaffray & Co. Sg Cowen & Co., LLC Underwriting Agreement

from S-1/A 45 pages Acorda Therapeutics, Inc. [___] Shares Common Stock Underwriting Agreement Dated [___], 2003 Banc of America Securities LLC Lazard Frères & Co. LLC U.S. Bancorp Piper Jaffray Inc. Rbc Dain Rauscher Inc. Underwriting Agreement